Isoprenoid Formation and Cell-Mediated Immunological Functions
Isoprenoid molecules are formed through a complex, multi-enzyme synthetic pathway. Main products of this pathway are cholesterol, bile acid and steroids. In addition, there are minor products of the pathway, such as dolichol, isopentenyl adenosine and ubiquinone. The early rate limiting step in all isoprenoid synthesis is the formation of mevalonate catalyzed by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Potent and specific competitive inhibitors of HMG-CoA reductase have been identified, which can block mevalonate formation and reduce cholesterol and other isoprenoid production. For example, mevinolin and several of its derivatives are increasingly being used clinically for treatment of hypercholesterolemia, particularly with view to improvement of cardiovascular disease (1,2,3).
KeywordsMevalonic Acid Isopentenyl Adenosine Isoprenoid Synthesis Lymphokine Activate Killer Activity Lymphokine Activate Killer Cell Activity
Unable to display preview. Download preview PDF.
- 4.R. B. Herberman, ed., Natural cell-mediated immunity against tumors, Academic Press, New York, London (1980).Google Scholar
- 5.R. B. Herberman, ed., NK cells and other natural effector cells, Academic Press, New York, London (1982).Google Scholar
- 6.R. B. Herberman and D. M. Callewaert, Mechanisms of Cytotoxicity by NK cells, Academic Press, New York, London (1985).Google Scholar
- 7.J. R. Ortaldo, L. Mason, J. P. Gerari, L. E. Henderson, W. Farrar, R. F. Hopkins III, R. B. Herberman, and H. Rabin, Effects of natural and recombinant IL-2 on regulation of IFN gamma production and natural killer activity: Lack of involvement of the TAC antigen for these immunoregula-tory events, Immunol. 133:799 (1984).Google Scholar
- 9.A. E. Grimm and S. A. Rosenberg, The human lymphokine activated killer cell phenomenon, Lymphokines 9:279 (1984).Google Scholar
- 10.A. E. Grimm, R. J. Robb, J. A. Roth, L. M. Neckers, L. B. Lachman, D. J. Wilson, and S. A. Rosenberg, Lymphokine-activated killer cell phenomenon, III, Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells, J. Exp. Med. 158:1356 (1983).PubMedCrossRefGoogle Scholar
- 22.M. Tsudo, C. K. Goldman, K. F. Bongiovanni, W. C. Chan, E. F. Winton, M. Yagita, E. A. Grimm, and T. A. Waldmann, The p75 peptide is the receptor for interleukin 2 on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells, Proc. Natl. Acad. Sci. USA 84:5394 (1987).PubMedCrossRefGoogle Scholar